Anixa Biosciences, Inc. - Common Stock (NQ:ANIX)

2.930 -0.020 (-0.68%)

Delayed Quote Updated: 10:44 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Anixa Biosciences, Inc. - Common Stock

< Previous 1 2 3 Next >

Could Anixa Biosciences (NASDAQ:ANIX) Be Developing The Vaccine To End One Of The Deadliest Types Of Breast Cancer?

August 10, 2023

Via ACCESSWIRE

Could Anixa Biosciences (NASDAQ: ANIX) Be Developing The Vaccine To End One Of The Deadliest Types Of Breast Cancer? ↗

August 09, 2023

Cancer is a disease that affects millions of people around the world. Historically, cancer vaccines have not been very successful in treating or preventing the disease. However, recent research on the...

Via Benzinga

Anixa Biosciences And 2 Other Penny Stocks Insiders Are Aggressively Buying ↗

July 24, 2023

The Dow Jones edged higher on Friday, recording gains for the tenth straight session. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects....

Via Benzinga

6 Analysts Have This to Say About Anixa Biosciences ↗

June 19, 2023

Via Benzinga

The Latest Analyst Ratings for Anixa Biosciences ↗

May 23, 2023

Via Benzinga

Expert Ratings for Anixa Biosciences ↗

April 18, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

February 23, 2023

Via Benzinga

Appreciating The Passing Of A Titan & Incorporating Alternative Data Signals ↗

December 27, 2022

Kathleen Moriarty, the lawyer who helped develop the structure for SPY and a true co-founder of the ETF industry, passed away last week.

Via Talk Markets

Benzinga's Top Ratings Upgrades, Downgrades For December 23, 2022 ↗

December 23, 2022

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

December 09, 2022

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 10, 2022

Gainers Reshape Lifesciences (NASDAQ:RSLS) shares increased by 12.7% to $0.34 during Monday's after-market session. The market value of their outstanding shares is at $1.2 million.

Via Benzinga

Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday ↗

September 19, 2022

Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

September 16, 2022

Via Benzinga

Recap Of Monday's Biotech Catalysts - End Of the Day Summary ↗

August 15, 2022

Via Benzinga

Anixa Initiates Patient Dosing in Initial-Stage Ovarian Cancer Study ↗

August 15, 2022

Anixa Biosciences (NASDAQ: ANIX) commenced treatment of the first patient in the clinical trial of its novel chimeric antigen receptor T-cell (CAR-T) therapy for ovarian cancer.

Via Benzinga

Can The Cure For Cancer Lie In Vaccines? ↗

August 11, 2022

Despite a global pandemic and war brimming in Europe, cancer remains the world’s second-deadliest killer in the world, taking over 600,000 lives

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 26, 2022

Via Benzinga

70 Biggest Movers From Friday ↗

May 02, 2022

Gainers GTY Technology Holdings Inc. (NASDAQ: GTYH) shares climbed 115.2% to close at $6.09 as the company agreed to be acquired by GI Partners. Vaxxinity, Inc. (NASDAQ: VAXX)...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

April 29, 2022

Via Benzinga

48 Stocks Moving In Friday's Mid-Day Session ↗

April 29, 2022

Gainers Belite Bio Inc. ADR (NASDAQ: BLTE) shares surged 144.8% to $14.69. Belite Bio priced its 6 million ADS IPO at $6 per ADS. GTY Technology Holdings Inc. (NASDAQ:...

Via Benzinga

3 Stocks Under $3 Insiders Are Aggressively Buying ↗

April 25, 2022

US crude oil futures traded lower on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

April 12, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

January 25, 2022

Gainers Anixa Biosciences (NASDAQ:ANIX) s...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 18, 2022

Gainers Brickell Biotech (NASDAQ:BBI) shares rose 37.0% to $0.28 during Tuesday's pre-market session. The market value of their outstanding shares is at $32.7 million...

Via Benzinga

3 Penny Stocks Insiders Are Buying ↗

January 13, 2022

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders intereste...

Via Benzinga

3 Penny Stocks Insiders Are Buying ↗

January 12, 2022

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders intereste...

Via Benzinga

4 Penny Stocks Insiders Are Buying ↗

January 11, 2022

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders intereste...

Via Benzinga

4 Penny Stocks Insiders Are Buying ↗

January 10, 2022

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

January 07, 2022

Gainers Absci (NASDAQ:ABSI) stock increased by 28.2% to $7.87 during Friday's regular session. As of 12:30 EST, Absci's stock is trading at a volume of 38.6...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

January 07, 2022

Before 10 am on Friday, 110 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: Humana (NYSE:HUM) was the biggest company on a market cap...

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.